Qing-Ke Chen, Qian Zou, Tao-Tao Sun, Feng-Lian Jiang, Lu Wang, Jun-Hong Fan
{"title":"Rare presentation of intraparenchymal renal artery aneurysm disguised as renal cell carcinoma: a case report and literature review.","authors":"Qing-Ke Chen, Qian Zou, Tao-Tao Sun, Feng-Lian Jiang, Lu Wang, Jun-Hong Fan","doi":"10.62347/JPNL3964","DOIUrl":null,"url":null,"abstract":"<p><p>Renal artery aneurysms (RAAs) are rare vascular abnormalities that are often detected incidentally, as most patients are asymptomatic and the lesions are discovered during imaging for unrelated conditions. Differentiating intraparenchymal RAAs (IPRAAs) from renal tumors using non-invasive imaging techniques remains challenging. Misdiagnosis as a renal malignancy, such as renal cell carcinoma (RCC), poses a significant risk of catastrophic hemorrhage if inadvertently subjected to biopsy or surgical procedures. We reported the case of a 75-year-old female with an IPRAA that mimicked RCC on contrast-enhanced computed tomography (CECT). However, a suspicious feeding artery to the renal mass was identified on computed tomography angiography (CTA) images. Further evaluation with positron emission tomography/magnetic resonance imaging (PET/MR) suggests the diagnosis of IPRAA. This was confirmed by digital subtraction angiography (DSA), and the aneurysm was successfully treated with transcatheter embolization. This case highlights the importance of including IPRAA in the differential diagnosis of renal masses and emphasizes the need for careful imaging evaluation to avoid potentially life-threatening complications from misdiagnosis.</p>","PeriodicalId":7572,"journal":{"name":"American journal of nuclear medicine and molecular imaging","volume":"15 6","pages":"272-277"},"PeriodicalIF":1.8000,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12816824/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of nuclear medicine and molecular imaging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.62347/JPNL3964","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Renal artery aneurysms (RAAs) are rare vascular abnormalities that are often detected incidentally, as most patients are asymptomatic and the lesions are discovered during imaging for unrelated conditions. Differentiating intraparenchymal RAAs (IPRAAs) from renal tumors using non-invasive imaging techniques remains challenging. Misdiagnosis as a renal malignancy, such as renal cell carcinoma (RCC), poses a significant risk of catastrophic hemorrhage if inadvertently subjected to biopsy or surgical procedures. We reported the case of a 75-year-old female with an IPRAA that mimicked RCC on contrast-enhanced computed tomography (CECT). However, a suspicious feeding artery to the renal mass was identified on computed tomography angiography (CTA) images. Further evaluation with positron emission tomography/magnetic resonance imaging (PET/MR) suggests the diagnosis of IPRAA. This was confirmed by digital subtraction angiography (DSA), and the aneurysm was successfully treated with transcatheter embolization. This case highlights the importance of including IPRAA in the differential diagnosis of renal masses and emphasizes the need for careful imaging evaluation to avoid potentially life-threatening complications from misdiagnosis.
期刊介绍:
The scope of AJNMMI encompasses all areas of molecular imaging, including but not limited to: positron emission tomography (PET), single-photon emission computed tomography (SPECT), molecular magnetic resonance imaging, magnetic resonance spectroscopy, optical bioluminescence, optical fluorescence, targeted ultrasound, photoacoustic imaging, etc. AJNMMI welcomes original and review articles on both clinical investigation and preclinical research. Occasionally, special topic issues, short communications, editorials, and invited perspectives will also be published. Manuscripts, including figures and tables, must be original and not under consideration by another journal.